Darling Ingredients Inc
Research Darling Ingredients Inc (DAR) on Bullrun: valuation model: 13.3% overvalued, market cap USD 9.51B, P/E 16.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDAR
- ExchangeNYSE
- CountryUnited States
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyUSD
- Valuation signal13.3% overvalued
- Market capUSD 9.51B
- P/E16.2
- Financial periodFY2026
- RevenueUSD 6.14B
- Revenue growth0.0%
- Net incomeUSD 62.80M
- Free cash flowUSD 679.24M
- Gross margin24.0%
Valuation Snapshot
Bullrun's latest valuation model marks Darling Ingredients Inc as 13.3% overvalued; latest market cap is USD 9.51B; P/E is 16.2.
Peer valuation comparison
Latest P/E is 16.19x versus a Consumer Defensive sector median of 17.24x (6.1% below).
Latest P/E is 16.19x versus a United States median of 23.85x (32.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 6.14B | USD 62.80M | USD 679.24M | 24.0% | 0.39 | USD 88.67M | USD 4.17B | USD 4.74B |
| FY2025 | USD 6.14B | USD 62.80M | USD 679.23M | 24.0% | 0.39 | USD 88.67M | USD 4.16B | USD 4.74B |
| FY2024 | USD 5.72B | USD 278.88M | USD 506.82M | 22.4% | 1.73 | USD 75.97M | USD 4.26B | USD 4.38B |
| FY2023 | USD 6.79B | USD 647.73M | USD 343.78M | 24.2% | 3.99 | USD 126.50M | USD 4.64B | USD 4.61B |
| FY2022 | USD 6.53B | USD 737.69M | USD 422.43M | 23.4% | 4.49 | USD 127.02M | USD 3.58B | USD 3.81B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 9.51B | 16.2 | n/a | n/a |
| 2025 | 2025-12-31 | USD 5.69B | 92.3 | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.35B | 19.5 | n/a | n/a |
| 2023 | 2023-12-29 | USD 7.95B | 11.3 | n/a | n/a |
| 2022 | 2022-12-30 | USD 10.03B | 14.0 | n/a | n/a |
| 2021 | 2021-12-31 | USD 11.21B | 17.8 | n/a | n/a |
About Darling Ingredients Inc
Darling Ingredients Inc. develops, produces, and sells sustainable natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America, and internationally. The Feed Ingredients segment collects and processes animal by-products into non-food grade oils and protein meals; bakery residuals into cookie meal used in poultry and swine rations; used cooking oil into non-food grade fats; and porcine and bovine blood into blood plasma powder and hemoglobin.
ETFs that hold Darling Ingredients Inc
Darling Ingredients Inc is one of the ten largest holdings of 6 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| iShares Agribusiness UCITS ETF USD (Acc) | 2.62% | 0.55% |
| WisdomTree BioRevolution UCITS ETF - USD Acc | 2.30% | 0.45% |
| Xtrackers MSCI Global SDG 9 Industry, Innovation & Infrastructure UCITS ETF 1C | 4.42% | 0.35% |
| VanEck Circular Economy UCITS ETF A USD Acc | 4.79% | 0.40% |
| Xtrackers MSCI Global SDG 11 Sustainable Cities UCITS ETF 1C | 4.77% | 0.35% |
| WisdomTree Recycling UCITS ETF USD Acc | 4.03% | 0.45% |
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
Is Darling Ingredients Inc overvalued or undervalued?
Bullrun's valuation model currently marks Darling Ingredients Inc as 13.3% overvalued.
What is Darling Ingredients Inc's market cap?
Darling Ingredients Inc's market capitalization is USD 9.51B.
What is Darling Ingredients Inc's P/E ratio?
Darling Ingredients Inc's price-to-earnings (P/E) ratio is 16.2.
What does Darling Ingredients Inc do?
Darling Ingredients Inc. develops, produces, and sells sustainable natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America, and internationally. The Feed Ingredients segment collects and processes animal by-products into non-food grade oils and protein meals; bakery residuals into cookie meal used in poultry and swine rations; used cooking oil into non-food grade fats; and porcine and bovine blood into blood plasma powder and hemoglobin.